Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing s...
The most useful thing about an opening plenary is usually not what gets said. It is who the organisers decided to put on...
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...
DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (...
What are Caidya’s major highlights for 2026 that will strengthen its presence in the global CRO market? And what a...
How will the new investment accelerate the development of TAVST01? When do you plan to launch the product in the market?...
US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...
Cytrellis Biosystems, Inc., a medical aesthetics company bridging the gap in skin health and restoration, has annou...
Japan-based PENTAX Medical, a HOYA Group company, has announced the expansion of its partnership with MAGENTIQ EYE, exte...
Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...
US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...
Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...
US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority share...
GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treat...
South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Gr...
China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...
Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...
Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech,...
South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies,...
Genentech, a member of the Roche Group, has announced plans to invest approximately $750 million in a new device fill-fi...
US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, h...
Aztron Medtech Corporation, a US-based orthopaedic device company, has announced that its Taiwan subsidiary, Astron Medt...
Australia-based OncoSil Medical, a medical device company developing targeted radiation therapies for difficult-to-treat...
